A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids

NCT02814019 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

255

Enrollment

INDUSTRY

Sponsor class

Stopped Interim analysis concluded to futility

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: Idebenone 150 mg film-coated tablets
DRUG: placebo

Sponsor

Santhera Pharmaceuticals